Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130503 · ClinicalTrials.gov registry record · NA
The Recovery in Stroke Using PAP Study
A NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT04130503: Recruiting NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by Yale University.
NCT04130503 is a NA study of Obstructive Sleep Apnea and Ischemic Stroke that is actively recruiting participants, run by Yale University. The registered enrollment target is 360 participants, above the 219-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04130503, a NA study of Obstructive Sleep Apnea and Ischemic Stroke, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treatment with usual care concerning the primary outcome of functional recovery.
Primary Outcome
The Modified Rankin Scale is a widely used measure of functional status and is sensitive to the full range of impairment from mild to severe. This objective examination scale with be video recorded by field staff and subsequently scored by the study neurologist blinded to randomization arm. The Modified Rankin Score (mRS) is a 6 point disability scale with possible scores ranging from 0 to 6. The higher the score, the more severe the disability. A score of 6 indicates the patient has expired (du
Conditions Studied
Interventions
- DEVICE PAP
- BEHAVIORAL HLE
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2025-10 |
| Phase | NA |
What NCT04130503 shows while recruiting
NCT04130503 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, above the 219-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% higher).
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which PAP is the first listed.
NCT04130503 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04130503 about?
NCT04130503 is a clinical study titled "The Recovery in Stroke Using PAP Study". The proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treatment with usual care concerning the primary outcome of functional recovery.
What is the current status of trial NCT04130503?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2019-09-01. Estimated completion is 2025-10.
What conditions does trial NCT04130503 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Ischemic Stroke.
What interventions are being tested in trial NCT04130503?
The interventions under investigation include: PAP (DEVICE), HLE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04130503?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04130503 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04130503's enrollment target sits among peer trials
360 19th of 155 higher than 135 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
- NCT04703166 · 360 participants
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI